SH2B1_HUMAN - dbPTM
SH2B1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SH2B1_HUMAN
UniProt AC Q9NRF2
Protein Name SH2B adapter protein 1
Gene Name SH2B1
Organism Homo sapiens (Human).
Sequence Length 756
Subcellular Localization Cytoplasm. Membrane . Nucleus. Shuttles between the nucleus and the cytoplasm..
Protein Description Adapter protein for several members of the tyrosine kinase receptor family. Involved in multiple signaling pathways mediated by Janus kinase (JAK) and receptor tyrosine kinases, including the receptors of insulin (INS), insulin-like growth factor I (IGF1), nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), platelet-derived growth factor (PDGF) and fibroblast growth factors (FGFs). In growth hormone (GH) signaling, autophosphorylated ('Tyr-813') JAK2 recruits SH2B1, which in turn is phosphorylated by JAK2 on tyrosine residues. These phosphotyrosines form potential binding sites for other signaling proteins. GH also promotes serine/threonine phosphorylation of SH2B1 and these phosphorylated residues may serve to recruit other proteins to the GHR-JAK2-SH2B1 complexes, such as RAC1. In leptin (LEP) signaling, binds to and potentiates the activation of JAK2 by globally enhancing downstream pathways. In response to leptin, binds simultaneously to both, JAK2 and IRS1 or IRS2, thus mediating formation of a complex of JAK2, SH2B1 and IRS1 or IRS2. Mediates tyrosine phosphorylation of IRS1 and IRS2, resulting in activation of the PI 3-kinase pathway. Acts as positive regulator of NGF-mediated activation of the Akt/Forkhead pathway; prolongs NGF-induced phosphorylation of AKT1 on 'Ser-473' and AKT1 enzymatic activity. Enhances the kinase activity of the cytokine receptor-associated tyrosine kinase JAK2 and of other receptor tyrosine kinases, such as FGFR3 and NTRK1. For JAK2, the mechanism seems to involve dimerization of both, SH2B1 and JAK2. Enhances RET phosphorylation and kinase activity. Isoforms seem to be differentially involved in IGF-I and PDGF-induced mitogenesis (By similarity)..
Protein Sequence MNGAPSPEDGASPSSPPLPPPPPPSWREFCESHARAAALDFARRFRLYLASHPQYAGPGAEAAFSRRFAELFLQHFEAEVARASGSLSPPILAPLSPGAEISPHDLSLESCRVGGPLAVLGPSRSSEDLAGPLPSSVSSSSTTSSKPKLKKRFSLRSVGRSVRGSVRGILQWRGTVDPPSSAGPLETSSGPPVLGGNSNSNSSGGAGTVGRGLVSDGTSPGERWTHRFERLRLSRGGGALKDGAGMVQREELLSFMGAEEAAPDPAGVGRGGGVAGPPSGGGGQPQWQKCRLLLRSEGEGGGGSRLEFFVPPKASRPRLSIPCSSITDVRTTTALEMPDRENTFVVKVEGPSEYIMETVDAQHVKAWVSDIQECLSPGPCPATSPRPMTLPLAPGTSFLTRENTDSLELSCLNHSESLPSQDLLLGPSESNDRLSQGAYGGLSDRPSASISPSSASIAASHFDSMELLPPELPPRIPIEEGPPTGTVHPLSAPYPPLDTPETATGSFLFQGEPEGGEGDQPLSGYPWFHGMLSRLKAAQLVLTGGTGSHGVFLVRQSETRRGEYVLTFNFQGKAKHLRLSLNEEGQCRVQHLWFQSIFDMLEHFRVHPIPLESGGSSDVVLVSYVPSSQRQQEPTTSHDPPQPPEPPSWTDPPQPGAEEASRAPEVAAAAAAAAKERQEKEKAGGGGVPEELVPVVELVPVVELEEAIAPGSEAQGAGSGGDAGVPPMVQLQQSPLGGDGEEGGHPRAINNQYSFV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
25PhosphorylationLPPPPPPSWREFCES
CCCCCCCCHHHHHHH
44.5326091039
48PhosphorylationFARRFRLYLASHPQY
HHHHHHHHHHHCCCC
8.93-
51PhosphorylationRFRLYLASHPQYAGP
HHHHHHHHCCCCCCC
32.8619060867
55PhosphorylationYLASHPQYAGPGAEA
HHHHCCCCCCCCHHH
20.2721253578
65PhosphorylationPGAEAAFSRRFAELF
CCHHHHHHHHHHHHH
20.16-
84PhosphorylationEAEVARASGSLSPPI
HHHHHHHCCCCCCCE
24.3021712546
86PhosphorylationEVARASGSLSPPILA
HHHHHCCCCCCCEEE
24.1528102081
88PhosphorylationARASGSLSPPILAPL
HHHCCCCCCCEEECC
30.2622617229
96PhosphorylationPPILAPLSPGAEISP
CCEEECCCCCCCCCC
21.8926055452
102PhosphorylationLSPGAEISPHDLSLE
CCCCCCCCCCCCCCC
14.0030206219
107PhosphorylationEISPHDLSLESCRVG
CCCCCCCCCCCCCCC
35.8328450419
110PhosphorylationPHDLSLESCRVGGPL
CCCCCCCCCCCCCCE
16.7128450419
123PhosphorylationPLAVLGPSRSSEDLA
CEEEECCCCCCCCCC
42.8923927012
125PhosphorylationAVLGPSRSSEDLAGP
EEECCCCCCCCCCCC
42.2823401153
126PhosphorylationVLGPSRSSEDLAGPL
EECCCCCCCCCCCCC
33.7430266825
135PhosphorylationDLAGPLPSSVSSSST
CCCCCCCCCCCCCCC
51.5623927012
136PhosphorylationLAGPLPSSVSSSSTT
CCCCCCCCCCCCCCC
24.8723927012
138PhosphorylationGPLPSSVSSSSTTSS
CCCCCCCCCCCCCCC
26.8423927012
139PhosphorylationPLPSSVSSSSTTSSK
CCCCCCCCCCCCCCC
26.5923927012
140PhosphorylationLPSSVSSSSTTSSKP
CCCCCCCCCCCCCCC
24.9723927012
141PhosphorylationPSSVSSSSTTSSKPK
CCCCCCCCCCCCCCC
37.3423927012
142PhosphorylationSSVSSSSTTSSKPKL
CCCCCCCCCCCCCCH
32.4223927012
143PhosphorylationSVSSSSTTSSKPKLK
CCCCCCCCCCCCCHH
32.7123927012
144PhosphorylationVSSSSTTSSKPKLKK
CCCCCCCCCCCCHHH
36.1323927012
145PhosphorylationSSSSTTSSKPKLKKR
CCCCCCCCCCCHHHC
51.3823403867
154PhosphorylationPKLKKRFSLRSVGRS
CCHHHCEEEHHHCCC
27.2330576142
157PhosphorylationKKRFSLRSVGRSVRG
HHCEEEHHHCCCHHH
33.9330576142
161PhosphorylationSLRSVGRSVRGSVRG
EEHHHCCCHHHHHHH
15.3821878491
165PhosphorylationVGRSVRGSVRGILQW
HCCCHHHHHHHHEEE
9.7021878491
189PhosphorylationAGPLETSSGPPVLGG
CCCCCCCCCCCCCCC
63.8428555341
211MethylationGGAGTVGRGLVSDGT
CCCCCCCCCCCCCCC
30.82115916833
215PhosphorylationTVGRGLVSDGTSPGE
CCCCCCCCCCCCCCC
35.0527251275
218PhosphorylationRGLVSDGTSPGERWT
CCCCCCCCCCCCHHC
36.4229255136
219PhosphorylationGLVSDGTSPGERWTH
CCCCCCCCCCCHHCH
36.1229255136
235MethylationFERLRLSRGGGALKD
HHHHHCCCCCCCCCC
52.9858859443
270MethylationPDPAGVGRGGGVAGP
CCCCCCCCCCCCCCC
37.8724129315
279PhosphorylationGGVAGPPSGGGGQPQ
CCCCCCCCCCCCCCH
53.8828555341
289UbiquitinationGGQPQWQKCRLLLRS
CCCCHHHCCEEEEEC
20.54-
296PhosphorylationKCRLLLRSEGEGGGG
CCEEEEECCCCCCCC
50.3428555341
320PhosphorylationKASRPRLSIPCSSIT
CCCCCCEECCCCCCC
26.2624275569
324PhosphorylationPRLSIPCSSITDVRT
CCEECCCCCCCCCEE
21.3028348404
325PhosphorylationRLSIPCSSITDVRTT
CEECCCCCCCCCEEC
35.9028857561
327PhosphorylationSIPCSSITDVRTTTA
ECCCCCCCCCEECEE
30.3228348404
352PhosphorylationVVKVEGPSEYIMETV
EEEEECCCCCEEEEC
54.6229116813
354PhosphorylationKVEGPSEYIMETVDA
EEECCCCCEEEECCH
15.2027642862
369PhosphorylationQHVKAWVSDIQECLS
HHHHHHHHHHHHHCC
20.4928102081
376PhosphorylationSDIQECLSPGPCPAT
HHHHHHCCCCCCCCC
39.2029978859
383PhosphorylationSPGPCPATSPRPMTL
CCCCCCCCCCCCCCC
25.1429978859
384PhosphorylationPGPCPATSPRPMTLP
CCCCCCCCCCCCCCC
22.4829978859
389PhosphorylationATSPRPMTLPLAPGT
CCCCCCCCCCCCCCC
28.1026074081
396PhosphorylationTLPLAPGTSFLTREN
CCCCCCCCCEECCCC
18.4226074081
397PhosphorylationLPLAPGTSFLTRENT
CCCCCCCCEECCCCC
24.9526074081
400PhosphorylationAPGTSFLTRENTDSL
CCCCCEECCCCCCCE
33.6526074081
404PhosphorylationSFLTRENTDSLELSC
CEECCCCCCCEEEEC
23.3928857561
406PhosphorylationLTRENTDSLELSCLN
ECCCCCCCEEEECCC
23.0028857561
410PhosphorylationNTDSLELSCLNHSES
CCCCEEEECCCCCCC
13.7428857561
415PhosphorylationELSCLNHSESLPSQD
EEECCCCCCCCCCCC
28.0128857561
417PhosphorylationSCLNHSESLPSQDLL
ECCCCCCCCCCCCEE
48.9028857561
420PhosphorylationNHSESLPSQDLLLGP
CCCCCCCCCCEECCC
41.44-
439PhosphorylationDRLSQGAYGGLSDRP
CCCCCCCCCCCCCCC
20.6725884760
494PhosphorylationVHPLSAPYPPLDTPE
CCCCCCCCCCCCCCC
19.7312551917
580PhosphorylationKAKHLRLSLNEEGQC
CEEEEEEECCCCCCH
23.7926657352
624PhosphorylationSDVVLVSYVPSSQRQ
CCEEEEEECCCCCCC
14.6519534553
649 (in isoform 3)Phosphorylation-15.5922210691
678 (in isoform 3)Phosphorylation-68.1722210691
753PhosphorylationPRAINNQYSFV----
CCCCCCCCCCC----
13.2427642862

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
96SPhosphorylationKinaseMAPK1P28482
GPS
96SPhosphorylationKinaseMAPK3P27361
GPS
161SPhosphorylationKinasePRKCAP17252
GPS
165SPhosphorylationKinasePRKCAP17252
GPS
439YPhosphorylationKinaseJAK1P23458
Uniprot
439YPhosphorylationKinaseJAK2O60674
Uniprot
439YPhosphorylationKinasePDGFR-FAMILY-GPS
439YPhosphorylationKinasePDGFR-Uniprot
494YPhosphorylationKinaseJAK1P23458
Uniprot
494YPhosphorylationKinaseJAK2O60674
Uniprot
753YPhosphorylationKinaseTRKAP04629
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SH2B1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference
145Phosphorylation148 (3)TA;Srs7498665
  • Waist circumference
  • Body mass index
25673412
19079261
23563607
19079260
154Phosphorylation148 (6)TA;Srs7498665
  • Waist circumference
  • Body mass index
25673412
19079261
23563607
19079260
157Phosphorylation148 (9)TA;Srs7498665
  • Waist circumference
  • Body mass index
25673412
19079261
23563607
19079260

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
FGFR3_HUMANFGFR3physical
11827956
NTRK1_HUMANNTRK1physical
9856458
GRB2_HUMANGRB2physical
9856458
JAK2_HUMANJAK2physical
9343427
JAK2_HUMANJAK2physical
12370803
INSR_HUMANINSRphysical
10594240
JAK2_HUMANJAK2physical
17565041
BRCA1_HUMANBRCA1physical
17565041
SH2B1_HUMANSH2B1physical
15767667
SH2B2_HUMANSH2B2physical
15767667
JAK2_HUMANJAK2physical
15767667
INSR_HUMANINSRphysical
15767667
IGF1R_HUMANIGF1Rphysical
15767667
CSAD_HUMANCSADphysical
25814554

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SH2B1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-88 AND SER-96, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-88 AND SER-96, AND MASSSPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-624, AND MASSSPECTROMETRY.

TOP